(3-Methylpyridin-2-yl)methanamine dihydrochloride is primarily utilized in pharmaceutical research and development as a key intermediate in the synthesis of various bioactive compounds. Its structure is particularly valuable in the design of molecules targeting neurological disorders, such as Alzheimer's disease and Parkinson's disease, due to its ability to interact with specific receptors in the brain. Additionally, it is employed in the creation of ligands for studying neurotransmitter systems, aiding in the understanding of brain function and the development of potential therapeutic agents. The compound is also explored in the field of medicinal chemistry for its potential in designing drugs with anti-inflammatory and analgesic properties. Its versatility makes it a valuable tool in the discovery of novel treatments for complex diseases.